COVID-19 Response

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Baylor College of Medicine

Treatment Resistant Depression: ECT Versus Ketamine (H-40701)



Treatment Resistant Depression Study - ECT Versus Ketamine

Baylor College of Medicine and the Michael E. DeBakey VA Medical Center are conducting a clinical trial in individuals between the ages of 21-75 to study the comparative effectiveness of ECT versus Ketamine in patients suffering from treatment-resistant depression. The study is sponsored by the Patient-Centered Outcomes Research Institute (PCORI) and is being conducted at several sites nationwide.

If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation will also be provided for time and travel.

All inquiries are confidential. Contact us at (713) 689-9856 or mood@bcm.edu.


Additional Information


Curious about ECT? Read The Truth About Electroconvulsive Therapy or watch a video about ECT.


Study Coordinator

Phone 1: 713–689–9856

IRB: H-40701




Back to topback-to-top